References
- Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012; 12:252-64; PMID:22437870; https://doi.org/https://doi.org/10.1038/nrc3239
- Lichty BD, Breitbach CJ, Stojdl DF, Bell JC. Going viral with cancer immunotherapy. Nat Rev Cancer 2014; 14:559-67; PMID:24990523; https://doi.org/https://doi.org/10.1038/nrc3770
- Brentjens RJ, Davila ML, Riviere I, Park J, Wang X, Cowell LG, Bartido S, Stefanski J, Taylor C, Olszewska M et al. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci Transl Med 2013; 5:177ra38; PMID:23515080; https://doi.org/https://doi.org/10.1126/scitranslmed.3005930
- Lizee G, Overwijk WW, Radvanyi L, Gao J, Sharma P, Hwu P. Harnessing the power of the immune system to target cancer. Annu Rev Med 2013; 64:71-90; PMID:23092383; https://doi.org/https://doi.org/10.1146/annurev-med-112311-083918
- Liu J, Tan Y, Zhang H, Zhang Y, Xu P, Chen J, Poh YC, Tang K, Wang N, Huang B. Soft fibrin gels promote selection and growth of tumorigenic cells. Nat Mater 2012; 11:734-41; PMID:22751180; https://doi.org/https://doi.org/10.1038/nmat3361
- Li Y, Luo S, Ma R, Liu J, Xu P, Zhang H, Tang K, Ma J, Zhang Y, Liang X et al. Upregulation of cytosolic phosphoenolpyruvate carboxykinase is a critical metabolic event in melanoma cells that repopulate tumors. Cancer Res 2015; 75:1191-6; PMID:25712344; https://doi.org/https://doi.org/10.1158/0008-5472.CAN-14-2615
- Tan Y, Tajik A, Chen J, Jia Q, Chowdhury F, Wang L, Chen J, Zhang S, Hong Y, Yi H et al. Matrix softness regulates plasticity of tumour-repopulating cells via H3K9 demethylation and Sox2 expression. Nat Commun 2014; 5:4619; PMID:25099074; https://doi.org/https://doi.org/10.1038/ncomms5619
- Tang K, Hu L, Ma J, Zhang H, Zhang Y, Li Y, Ma R, Luo S, Liu D, Long G et al. Brief report: human mesenchymal stem-like cells facilitate floating tumorigenic cell growth via glutamine-ammonium cycle. Stem Cells 2015; 33:2877-84; PMID:26031226; https://doi.org/https://doi.org/10.1002/stem.2076
- Aguirre-Ghiso JA. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer 2007; 7:834-46; PMID:17957189; https://dx.do i.org/https://doi.org/10.1038/nrc2256
- Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005; 438:820-7; PMID:16341007; https://doi.org/https://doi.org/10.1038/nature04186
- Sceneay J, Smyth MJ, Möller A. The pre-metastatic niche: Finding common ground. Cancer Metastasis Rev 2013; 32:449-64; PMID:23636348; https://doi.org/https://doi.org/10.1007/s10555-013-9420-1
- Nassar D, Blanpain C. Cancer stem cells: Basic concepts and therapeutic. Annu Rev Pathol 2016; 11:47-76; PMID:27193450; https://doi.org/https://doi.org/10.1146/annurev-pathol-012615-044438
- Yu X, Li H, Ren X. Implications interaction between regulatory T cells and cancer stem cells. Int J Cancer 2012; 131:1491-8; PMID:22592629; https://doi.org/https://doi.org/10.1002/ijc.27634
- Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: Important and underappreciated mediators of cell-to-cell communication. Leukemia 2006; 20:1487-95; PMID:16791265; https://doi.org/https://doi.org/10.1038/sj.leu.2404296
- Tang K, Zhang Y, Zhang H, Xu P, Liu J, Ma J, Lv M, Li D, Katirai F, Shen GX et al. Delivery of chemotherapeutic drugs in tumour cell derived microparticles. Nat Commun 2012; 3:1282; PMID:23250412; https://doi.org/https://doi.org/10.1038/ncomms2282
- Ran L, Tan X, Li Y, Zhang H, Ma R, Ji T, Dong W, Tong T, Liu Y, Chen D et al. Delivery of oncolytic adenovirus into the nucleus of tumorigenic cells by tumor microparticles for virotherapy. Biomaterials 2016; 89:56-66; PMID:26950165; https://doi.org/https://doi.org/10.1016/j.biomaterials.2016.02.025
- Ma J, Zhang Y, Tang K, Zhang H, Yin X, Li Y, Xu P, Sun Y, Ma R, Ji T et al. Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles. Cell Res 2016; 26:713-27; PMID:27167569; https://doi.org/https://doi.org/10.1038/cr.2016.53
- Jin X, Ma J, Liang X, Tang K, Liu Y, Yin X, Zhang Y, Zhang H, Xu P, Chen D et al. Pre-instillation of tumor microparticles enhances intravesical chemotherapy of nonmuscle-invasive bladder cancer through a lysosomal pathway. Biomaterials 2017; 113:93-104; PMID:27810645; https://doi.org/https://doi.org/10.1016/j.biomaterials.2016.10.036
- Elvington M, Scheiber M, Yang X, Lyons K, Jacqmin D, Wadsworth C, Marshall D, Vanek K, Tomlinson S. Complement-dependent modulation of antitumor immunity following radiation therapy. Cell Rep 2014; 8:818-30; PMID:25066124; https://doi.org/https://doi.org/10.1016/j.celrep.2014.06.051
- Hellevik T, Martinez-Zubiaurre I. Radiotherapy and the tumor stroma: The importance of dose and fractionation. Front Oncol 2014; 4:1; PMID:24478982; https://doi.org/https://doi.org/10.3389/fonc.2014.00001
- Delgoffe GM. Filling the tank: Keeping antitumor T cells metabolically fit for the long Haul. Cancer Immunol Res 2016; 4:1001-1006; PMID:27908931; https://doi.org/https://doi.org/10.1158/2326-6066.CIR-16-0244
- Klug F, Prakash H, Huber PE, Seibel T, Bender N, Halama N, Pfirschke C, Voss RH, Timke C, Umansky L et al. Low-dose irradiation programs macrophage differentiation to an iNOS+/M1 phenotype that orchestrates effective T cell immunotherapy. Cancer Cell 2013; 24:589-602; PMID:24209604; https://dx. doi.org/https://doi.org/10.1016/j.ccr.2013.09.014
- Balkwill FR, Capasso M, Hagemann T. The tumor microenvironment at a glance. J Cell Sci 2012; 125:5591-6; PMID:23420197; https://doi.org/https://doi.org/10.1242/jcs.116392
- Liu Y, Cao X. The origin and function of tumor-associated macrophages. Cell Mol Immunol 2015; 12:1-4; PMID:25220733; https://doi.org/https://doi.org/10.1038/cmi.2014.83
- Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012; 12:253-68; PMID:22437938; https://doi.org/https://doi.org/10.1038/nri3175
- Bayne LJ, Beatty GL, Jhala N, Clark CE, Rhim AD, Stanger BZ, Vonderheide RH. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 2012; 2:822-35; PMID:22698406; https://doi.org/https://doi.org/10.1016/j.ccr.2012.04.025
- Islam SA, Luster AD. T cell homing to epithelial barriers in allergic disease. Nat Med 2012; 18:705-15; PMID:22561834; https://doi.org/https://doi.org/10.1038/nm.2760
- De Monte L, Reni M, Tassi E, Clavenna D, Papa I, Recalde H, Braga M, Di Carlo V, Doglioni C, Protti MP. Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. J Exp Med 2011; 208:469-78; PMID:21339327; https://doi.org/https://doi.org/10.1084/jem.20101876
- Suvorava T, Luksha L, Bulanova KY, Lobanok LM. Dose-rate dependent effects of ionizing radiation on vascular reactivity. Radiat Prot Dosimetry 2006; 122:543-5; PMID:17132674; https://doi.org/https://doi.org/10.1093/rpd/ncl432
- Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009; 9:581-593; PMID:19498381; https://doi.org/https://doi.org/10.1038/nri2567
- Li D, Jia H, Zhang H, Lv M, Liu J, Zhang Y, Huang T, Huang B. TLR4 signaling induces the release of microparticles by tumor cells that regulate inflammatory cytokine IL-6 of macrophages via microRNA let-7b. Oncoimmunology 2012; 1:687-693; PMID:22934260; https://doi.org/https://doi.org/10.4161/onci.19854
- Ma R, Ji T, Chen D, Dong W, Zhang H, Yin X, Ma J, Liang X, Zhang Y, Shen G et al. Tumor cell-derived microparticles polarize M2 tumor-associated macrophages for tumor progression. Oncoimmunology 2016; 5:e1118599; PMID:27141404; https://doi.org/https://doi.org/10.1080/2162402X.2015.1118599
- Yang Z, Zhang B, Li D, Lv M, Huang C, Shen GX, Huang B. Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model. PLoS One 2010; 5:e8922; PMID:20111717; https://doi.org/https://doi.org/10.1371/journal.pone.0008922
- Formenti SC, Demaria S. Combining radiotherapy and cancer immunotherapy: A paradigm shift. J Natl Cancer Inst 2013; 105:256-65; PMID:23291374; https://doi.org/https://doi.org/10.1093/jnci/djs629
- Tesniere A, Apetoh L, Ghiringhelli F, Joza N, Panaretakis T, Kepp O, Schlemmer F, Zitvogel L, Kroemer G. Immunogenic cancer cell death: A key-lock paradigm. Curr Opin Immunol 2008; 20:504-11; PMID:18573340; https://doi.org/https://doi.org/10.1016/j.coi.2008.05.007
- Reits EA, Hodge JW, Herberts CA, Groothuis TA, Chakraborty M, Wansley EK, Camphausen K, Luiten RM, de Ru AH, Neijssen J et al. Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy. J Exp Med 2006; 203:1259-71; PMID:16636135; https://doi.org/https://doi.org/10.1084/jem.20052494
- Vereecque R, Buffenoir G, Gonzalez R, Cambier N, Hetuin D, Bauters F, Fenaux P, Quesnel B. γ-Ray irradiation induces B7.1 expression in myeloid leukaemic cells. Br J Haematol 2000; 108:825-31; PMID:10792289; https://doi.org/https://doi.org/10.1046/j.1365-2141.2000.01967.x
- Baluna RG, Eng TY, Thomas CR. Adhesion molecules in radiotherapy. Radiat Res 2006; 166:819-31; PMID:17149971; https://doi.org/https://doi.org/10.1667/RR0380.1
- Gasser S, Orsulic S, Brown EJ, Raulet DH. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 2005; 436:1186-90; PMID:15995699; https://doi.org/https://doi.org/10.1038/nature03884
- Chakraborty M, Abrams SI, Camphausen K, Liu K, Scott T, Coleman CN, Hodge JW. Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy. J Immunol 2003; 170:6338-47; PMID:12794167; https://doi.org/https://doi.org/10.4049/jimmunol.170.12.6338
- Qu Y, Jin S, Zhang A, Zhang B, Shi X, Wang J, Zhao Y. Gamma-ray resistance of regulatory CD4+CD25+Foxp3+ T cells in mice. Radiat Res 2010; 173:148-57; PMID:20095846; https://doi.org/https://doi.org/10.1667/RR0978.1
- Chiang CS, Fu SY, Wang SC, Yu CF, Chen FH, Lin CM, Hong JH. Irradiation promotes an m2 macrophage phenotype in tumor hypoxia. Front Oncol 2012; 2:89; PMID:22888475; https://doi.org/https://doi.org/10.3389/fonc.2012.00089
- Zou W, Wolchok JD, Chen L. PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations. Sci Transl Med 2016; 8:328rv4; PMID:26936508; https://doi.org/https://doi.org/10.1126/scitranslmed.aad7118
- Mills CD, Lenz LL, Harris RA. A breakthrough: Macrophage-directed cancer immunotherapy. Cancer Res 2016; 76:513-6; PMID:26772756; https://doi.org/https://doi.org/10.1158/0008-5472.CAN-15-1737
- Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 2010; 7:653-64; PMID:20838415; https://doi.org/https://doi.org/10.1038/nrclinonc.2010.139